D
Do Young Kim
Researcher at Yonsei University
Publications - 737
Citations - 18320
Do Young Kim is an academic researcher from Yonsei University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 58, co-authored 674 publications receiving 15091 citations. Previous affiliations of Do Young Kim include University of Ulsan & Fred Hutchinson Cancer Research Center.
Papers
More filters
Journal Article
Clinical outcome of pulmonary resections in patients with pulmonary metastasis of hepatocellular carcinoma
Kyung Kyu Kim,Ja Kyung Kim,Do Young Kim,Sang Hoon Ahn,Chae Yoon Chon,Young Myoung Moon,Kyung Young Chung,Kwang Hyub Han +7 more
TL;DR: The surgical resections of a solitary pulmonary metastasis from HCC in highly selected patients might be an effective treatment modalities for prolonged survival.
Journal ArticleDOI
[A comparison of 24- vs. 48-week peginterferon plus ribavirin in patients with genotype 1 chronic hepatitis C].
Mi Na Kim,Ki Tae Yoon,Jun Yong Park,Do Young Kim,Sang Hoon Ahn,Chae Yoon Chon,Kwang Hyub Han +6 more
TL;DR: The 24-week plus additional split 24- week therapy following failure is a useful treatment strategy for patients with genotype 1 chronic hepatitis C.
Journal ArticleDOI
Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients.
David Sooik Kim,Soo-Young Park,Beom Kyung Kim,Jun Yong Park,Do Young Kim,Kwang Hyub Han,Yu Rim Lee,Won Young Tak,Young Oh Kweon,Inkyung Jung,Minkyung Han,Eun Hwa Kim,Sang Hoon Ahn,Seung Up Kim +13 more
TL;DR: In this article, the authors investigated whether the revised Korean Association for the Study of Liver (KASL) guideline implementation reduced the risk of CHB-related hepatocellular carcinoma (HCC) in patients with cirrhosis in South Korea.
Journal ArticleDOI
Total Lesion Glycolysis on 18F-FDG PET/CT Is a Better Prognostic Factor Than Tumor Dose on 90Y PET/CT in Patients With Hepatocellular Carcinoma Treated With 90Y Transarterial Radioembolization
Sang Hyun Hwang,Hye-Suk Hong,Dongwoo Kim,Gyoung Min Kim,Hye Won Lee,Misu Lee,Do Young Kim,Mi-Ae Park,Mijin Yun +8 more
TL;DR: TLG, a parameter incorporating both the degree of 18F-FDG uptake and amount of metabolically active tumor volume on pretreatment 18F -FDG PET/CT, is a better prognostic factor than TD on 90YPET/CT for predicting OS in HCC patients treated with 90Y TARE.
Journal ArticleDOI
Sucralfate protection against ethanol‐induced injury of rat gastric mucosa in vitro and in vivo
TL;DR: It was demonstrated that sucralfate protection in vivo is dose‐dependent and prolonged, lasting for at least 5 h at a dose of 200 mg/kg and can occur via mechanisms other than minimization of acid/peptic attack.